Capecitabine and oxaliplatin as induction and concomitant with radiotherapy in rectal cancer: A phase II study

被引：0
|
作者：
Gutierrez, J. A.
Martinez-Martinez, G.
Silva, A. J.
Gomez Rangel, J., Sr.
Palmerin, M.
Gutierrez, M.
Garcia, B.
机构：
[1] Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico
[2] Ctr Med Nacl Siglo XXI IMSS, Mexico City, DF, Mexico
[3] Hosp Oncol Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico
[4] IMSS, Hosp Reg Especialidades Orizaba, Orizaba, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
604
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II–III rectal cancer
    Ramon Salazar
    Matilde Navarro
    Ferran Losa
    Vicente Alonso
    Manel Gallén
    Fernando Rivera
    Manuel Benavides
    Pilar Escudero
    Encarnación González
    Bartomeu Massutí
    Auxiliadora Gómez
    Margarita Majem
    Enrique Aranda
    [J]. Clinical and Translational Oncology, 2012, 14 : 592 - 598
  • [2] Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer
    Salazar, Ramon
    Navarro, Matilde
    Losa, Ferran
    Alonso, Vicente
    Gallen, Manel
    Rivera, Fernando
    Benavides, Manuel
    Escudero, Pilar
    Gonzalez, Encarnacion
    Massuti, Bartomeu
    Gomez, Auxiliadora
    Majem, Margarita
    Aranda, Enrique
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 592 - 598
  • [3] Phase II Trial of Concomitant Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine and Intensity-Modulated Radiotherapy (IMRT) in Rectal Cancer
    Joan Manel Gasent Blesa
    Javier Garde Noguera
    Juan Bautista Laforga Canales
    Vicent Giner Bosch
    Antonio Alberola
    Miguel Soler Tortosa
    Miguel Peris Godoy
    Jose Luis Sanchez
    Mariano Provencio Pulla
    Vicente Alberola Candel
    [J]. Journal of Gastrointestinal Cancer, 2012, 43 (4) : 553 - 561
  • [4] A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
    Zhao, Lin
    Bai, Chunmei
    Shao, Yajuan
    Guan, Mei
    Jia, Ning
    Xiao, Yi
    Qiu, Huizhong
    Zhang, Fuquan
    Yang, Ti
    Zhong, Guangxi
    Chen, Shuchang
    [J]. CANCER LETTERS, 2011, 310 (02) : 134 - 139
  • [5] Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study
    Carlomagno, C.
    Farella, A.
    Bucci, L.
    D'Armiento, F. P.
    Pesce, G.
    Pepe, S.
    Cannella, L.
    Pacelli, R.
    De Stefano, A.
    Solla, R.
    D'Armiento, M. R.
    De Placido, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (05) : 906 - 912
  • [6] Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
    Machiels, JP
    Duck, L
    Honhon, B
    Coster, B
    Coche, JC
    Scalliet, P
    Humblet, Y
    Aydin, S
    Kerger, J
    Remouchamps, V
    Canon, JL
    Van Maele, P
    Gilbeau, L
    Laurent, S
    Kirkove, C
    Octave-Prignot, M
    Baurain, JF
    Kartheuser, A
    Sempoux, C
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (12) : 1898 - 1905
  • [7] Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
    Krishnan, Sunil
    Janjan, Nora A.
    Skibber, John M.
    Rodriguez-Bigas, Miguel A.
    Wolff, Robert A.
    Das, Prajnan
    Delclos, Marc E.
    Chang, George J.
    Hoff, Paulo M.
    Eng, Cathy
    Brown, Thomas D.
    Crane, Christopher H.
    Feig, Barry W.
    Morris, Jeffrey
    Vadhan-Raj, Saroj
    Hamilton, Stanley R.
    Lin, Edward H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : 762 - 771
  • [8] Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for Stage II and III rectal cancer
    Jin, Jing
    Li, Ye-Xiong
    Wang, Jin-Wan
    Wang, Wei-Hu
    Liu, Yue-Ping
    Wang, Kai
    Fang, Hui
    Zhou, Zhi-Xiang
    Zhou, Ai-Ping
    Yu, Zi-Hao
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 671 - 677
  • [9] Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as adjuvant treatment for stage II and III rectal cancer
    Jin, J.
    Li, Y. X.
    Wang, W. H.
    Liu, Y. P.
    Wang, K.
    Fang, H.
    Zhou, Z. X.
    Zhou, A. P.
    Wang, J. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S284 - S285
  • [10] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    [J]. Angiogenesis, 2012, 15 : 141 - 150
12345